BM
Brandywine Managers Portfolio holdings
AUM
$101M
This Quarter Return
+3.69%
1 Year Return
+24.43%
3 Year Return
+74.73%
5 Year Return
+125.12%
10 Year Return
+356.43%
AUM
$94.9M
AUM Growth
+$94.9M
(+2%)
Cap. Flow
+$244K
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
83.48%
Holding
37
New
2
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Klaviyo
KVYO
|
$358K |
| 2 |
Twilio
TWLO
|
$255K |
| 3 |
UiPath
PATH
|
$121K |
Top Sells
| 1 |
iShares MSCI ACWI ETF
ACWI
|
$490K |
Sector Composition
| 1 | Technology | 44.59% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 0.99% |
| 4 | Consumer Discretionary | 0.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Moderna
MRNA
$9.37B
| $395K | 0.42% | 9,510 | – | – |
|
27
Novo Nordisk
NVO
$251B
| $363K | 0.38% | 4,222 | – | – |
|
|
28
Klaviyo
KVYO
$9.73B
| $358K | 0.38% | +8,692 | New | +$358K |
|
29
Viking Therapeutics
VKTX
$3.04B
| $325K | 0.34% | 8,082 | – | – |
|
30
Guardant Health
GH
$8.41B
| $313K | 0.33% | 10,233 | – | – |
|
31
Structure Therapeutics
GPCR
$1.11B
| $300K | 0.32% | 11,057 | – | – |
|
32
Beam Therapeutics
BEAM
$1.66B
| $280K | 0.3% | 11,306 | – | – |
|
33
Mobileye
MBLY
$11.4B
| $260K | 0.27% | 13,067 | – | – |
|
|
34
Twilio
TWLO
$16.2B
| $255K | 0.27% | +2,357 | New | +$255K |
|
35
Relay Therapeutics
RLAY
$619M
| $158K | 0.17% | 38,429 | – | – |
|
36
10x Genomics
TXG
$1.74B
| $145K | 0.15% | 10,073 | – | – |
|
37
AbCellera Biologics
ABCL
$1.25B
| $83.5K | 0.09% | 28,488 | – | – |
|